California State Teachers Retirement System (CalSTRS)’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8K Sell
1,907
-4,484
-70% -$79.5K ﹤0.01% 2256
2026
Q1
$121K Sell
6,391
-879
-12% -$14.2K ﹤0.01% 2224
2025
Q4
$127K Sell
7,270
-103
-1% -$1.94K ﹤0.01% 2258
2025
Q3
$152K Buy
7,373
+5
+0.1% +$121 ﹤0.01% 2261
2025
Q2
$157K Buy
7,368
+2,828
+62% +$64.5K ﹤0.01% 2271
2025
Q1
$87.6K Sell
4,540
-2,200
-33% -$44.1K ﹤0.01% 2345
2024
Q4
$120K Buy
6,740
+356
+6% +$6.9K ﹤0.01% 2376
2024
Q3
$140K Buy
6,384
+41
+0.6% +$573 ﹤0.01% 2394
2024
Q2
$49.5K Sell
6,343
-131,303
-95% -$709K ﹤0.01% 2436
2024
Q1
$570K Sell
137,646
-5,603
-4% -$22.3K ﹤0.01% 2081
2023
Q4
$374K Sell
143,249
-5,752
-4% -$11.8K ﹤0.01% 2335
2023
Q3
$279K Sell
149,001
-12,286
-8% -$23.4K ﹤0.01% 2439
2023
Q2
$405K Buy
+161,287
New +$294K ﹤0.01% 2402
2022
Q2
Sell
-11,186
Closed -$27K 3284
2022
Q1
$27K Sell
11,186
-2,485
-18% -$6.26K ﹤0.01% 3148
2021
Q4
$37K Sell
13,671
-577
-4% -$2.77K ﹤0.01% 3203
2021
Q3
$71K Sell
14,248
-17,017
-54% -$122K ﹤0.01% 3067
2021
Q2
$233K Buy
+31,265
New +$205K ﹤0.01% 2967

Other funds holding SMMT

California State Teachers Retirement System (CalSTRS)'s SMMT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Summit Therapeutics (SMMT) stake by 70% in Q2 2026, selling an estimated $79.5K and leaving 1,907 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

California State Teachers Retirement System (CalSTRS) first reported a position in SMMT in Q2 2021 and has held it in 17 quarters since. The position peaked at $570K in Q1 2024. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,907 shares of Summit Therapeutics worth $27.8K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 4,484 Summit Therapeutics shares in Q2 2026, an estimated $79.5K.
  • Summit Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2256 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Summit Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Summit Therapeutics position peaked at $570K in Q1 2024.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.